Phase structure of lattice QCD for general number of flavors

We investigate the phase structure of lattice QCD for the general number of flavors in the parameter space of gauge coupling constant and quark mass, employing the one-plaquette gauge action and the standard Wilson quark action. Performing a series of simulations for the number of flavors $N_F=6$--360 with degenerate-mass quarks, we find that when $N_F \ge 7$ there is a line of a bulk first order phase transition between the confined phase and a deconfined phase at a finite current quark mass in the strong coupling region and the intermediate coupling region. The massless quark line exists only in the deconfined phase. Based on these numerical results in the strong coupling limit and in the intermediate coupling region, we propose the following phase structure, depending on the number of flavors whose masses are less than $\Lambda_d$ which is the physical scale characterizing the phase transition in the weak coupling region: When $N_F \ge 17$, there is only a trivial IR fixed point and therefore the theory in the continuum limit is free. On the other hand, when $16 \ge N_F \ge 7$, there is a non-trivial IR fixed point and therefore the theory is non-trivial with anomalous dimensions, however, without quark confinement. Theories which satisfy both quark confinement and spontaneous chiral symmetry breaking in the continuum limit exist only for $N_F \le 6$.Comment: RevTeX, 20 pages, 43 PS figure

High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: a prospective study

<p>Abstract</p> <p>Introduction</p> <p>Even though sepsis is one of the common causes of children morbidity and mortality, specific inflammatory markers for identifying sepsis are less studied in children. The main aim of this study was to compare the levels of high-mobility group box-1 protein (HMGB1), Lipopolysaccharide-binding protein (LBP), Interleukin-6 (IL-6) and C-reactive protein (CRP) between infected children without systemic inflammatory response syndrome (SIRS) and children with severe and less severe sepsis. The second aim was to examine HMGB1, LBP, IL6 and CRP as markers for of bacteraemia.</p> <p>Methods</p> <p>Totally, 140 children with suspected or proven infections admitted to the Children's Clinical University Hospital of Latvia during 2008 and 2009 were included. Clinical and demographical information as well as infection focus were assessed in all patients. HMGB1, LBP, IL-6 and CRP blood samples were determined. Children with suspected or diagnosed infections were categorized into three groups of severity of infection: (i) infected without SIRS (n = 36), (ii) sepsis (n = 91) and, (iii) severe sepsis (n = 13). They were furthermore classified according bacteraemia into (i) bacteremia (n = 30) and (ii) no bacteraemia (n = 74).</p> <p>Results</p> <p>There was no statistically significant difference in HMGB1 levels between children with different levels of sepsis or with and without bacteraemia. The levels of LBP, IL-6 and CRP were statistically significantly higher among patients with sepsis compared to those infected but without SIRS (<it>p </it>< 0.001). Furthermore, LBP, IL-6 and CRP were significantly higher in children with severe sepsis compared to those ones with less severe sepsis (<it>p </it>< 0.001). Median values of LBP, IL6 and CRP were significantly higher in children with bacteraemia compared to those without bacteraemia. The area under the receiver operating curve (ROC) for detecting bacteraemia was 0.87 for both IL6 and CRP and 0.82 for LBP, respectively.</p> <p>Conclusion</p> <p>Elevated levels of LBP, IL-6 and CRP were associated with a more severe level of infection in children. Whereas LBP, IL-6 and CRP seem to be good markers to detect patients with bacteraemia, HMGB1 seem to be of minor importance. LBP, IL-6 and CRP levels may serve as good biomarkers for identifying children with severe sepsis and bacteraemia and, thus, may be routinely used in clinical practice.</p

Revisiting symmetries of lattice fermions via spin-flavor representation

Employing the spin-flavor representation, we investigate the structures of the doubler-mixing symmetries and the mechanisms of their spontaneous breakdown in four types of lattice fermion formulation. We first revisit the U(4)\timesU(4)A symmetries of the naive fermion with the vanishing bare mass m, and re-express them in terms of the spin-flavor representation. We apply the same method to the Wilson fermion, which possesses only the U(1) vector symmetry for general values of m. For a special value of m, however, there emerges an additional U(1) symmetry to be broken by pion condensation. We also explore two types of minimally doubled fermion, and discover a similar kind of symmetry enhancement and its spontaneous breakdown.Comment: 25 pages, no figure;v2 typos corrected;v3 Sec.2 is shortened. To appear in JHE

Serum Lipopolysaccharide Binding Protein Levels Predict Severity of Lung Injury and Mortality in Patients with Severe Sepsis

Background: There is a need for biomarkers insuring identification of septic patients at high-risk for death. We performed a prospective, multicenter, observational study to investigate the time-course of lipopolysaccharide binding protein (LBP) serum levels in patients with severe sepsis and examined whether serial serum levels of LBP could be used as a marker of outcome. Methodology/Principal Findings: LBP serum levels at study entry, at 48 hours and at day-7 were measured in 180 patients with severe sepsis. Data regarding the nature of infections, disease severity, development of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), and intensive care unit (ICU) outcome were recorded. LBP serum levels were similar in survivors and non-survivors at study entry (117.4±75.7 µg/mL vs. 129.8±71.3 µg/mL, P = 0.249) but there were significant differences at 48 hours (77.2±57.0 vs. 121.2±73.4 µg/mL, P<0.0001) and at day-7 (64.7±45.8 vs. 89.7±61.1 µg/ml, p = 0.017). At 48 hours, LBP levels were significantly higher in ARDS patients than in ALI patients (112.5±71.8 µg/ml vs. 76.6±55.9 µg/ml, P = 0.0001). An increase of LBP levels at 48 hours was associated with higher mortality (odds ratio 3.97; 95%CI: 1.84–8.56; P<0.001). Conclusions/Significance: Serial LBP serum measurements may offer a clinically useful biomarker for identification of patients with severe sepsis having the worst outcomes and the highest probability of developing sepsis-induced ARDS

Le kyste hydatique du foie. Approche clinique et thérapeutique. À propos de 97 cas opérés dans un chu de Tunisie centrale

Objective - The hydatid cyst of the liver; an anthropozoonosis due to a cestode (Echinococcus granulosus), the usual host of which is the dog, is not common in Western Europe, but has been diagnosed in patients coming from Southern Europe and Northern Africa. This retrospective study describes the clinical, diagnostic, and therapeutic aspects of the hydatid echinococcosis. Material and methods - We examined the evolution of 97 consecutive patients admitted and treated surgically fora hydatid cyst in 1998 in a Central Tunisia university hospital. Results - The patients' mean age was 41 +/- 19.8 years (range: 4 and 85). The most common cause for consulting a physician was pain (79.4 %), usually located in the right upper quadrant Sometimes, the disease occurred with the onset of serious complications. In some cases it was also discovered fortuitously. The most sensitive diagnostic method was abdominal echotomography, positive in every case. Serology and TD scan were also performed in some cases. The treatment was surgery with two methods: a radical and a conservative one; 16.5% of postoperative complications are reported for both techniques (fistula and surinfection). Conclusion - The hydatid disease of the liver is a histologically benign pathology, but it may become dangerous because of possible serious complications. Although there are efficacious therapeutic weapons, prevention and education of the population living in endemic zones is strongly advised. (C) 2000 Editions scientifiques et medicales Elsevier SAS